#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	238	CRP	633	633	99.53	CRP.l15.c30.ctg.1	914	13.4	0	.	p	.	0	K29T	NONSYN	85	87	AAG	171	173	ACG	10;11;13	A;C;G	10;11;13	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	142	Chlamydophila_psittaci_16S	1507	117	92.31	Chlamydophila_psittaci_16S.l15.c17.ctg.1	130	12.0	0	.	n	.	0	A888G	SNP	888	888	A	6	6	G	3	G	3	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	142	Chlamydophila_psittaci_16S	1507	117	92.31	Chlamydophila_psittaci_16S.l15.c17.ctg.1	130	12.0	0	.	n	.	0	C897G	SNP	897	897	C	15	15	G	5	G	5	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	142	Chlamydophila_psittaci_16S	1507	117	92.31	Chlamydophila_psittaci_16S.l15.c17.ctg.1	130	12.0	0	.	n	.	0	T898C	SNP	898	898	T	16	16	C	6	C	6	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	142	Chlamydophila_psittaci_16S	1507	117	92.31	Chlamydophila_psittaci_16S.l15.c17.ctg.1	130	12.0	0	.	n	.	0	G906T	SNP	906	906	G	24	24	T	8	T	8	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	142	Chlamydophila_psittaci_16S	1507	117	92.31	Chlamydophila_psittaci_16S.l15.c17.ctg.1	130	12.0	0	.	n	.	0	G908A	SNP	908	908	G	26	26	A	10	A	10	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	142	Chlamydophila_psittaci_16S	1507	117	92.31	Chlamydophila_psittaci_16S.l15.c17.ctg.1	130	12.0	0	.	n	.	0	A918T	SNP	918	918	A	36	36	T	13	T	13	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	142	Chlamydophila_psittaci_16S	1507	117	92.31	Chlamydophila_psittaci_16S.l15.c17.ctg.1	130	12.0	0	.	n	.	0	A943G	SNP	943	943	A	61	61	G	25	G	25	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	142	Chlamydophila_psittaci_16S	1507	117	92.31	Chlamydophila_psittaci_16S.l15.c17.ctg.1	130	12.0	0	.	n	.	0	G991T	SNP	991	991	G	109	109	T	10	T	10	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	143	892	Escherichia_coli_EF_Tu	1185	1185	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1247	35.3	0	HET	.	.	.	C954T	.	954	954	C	978	978	C	46	C,T	27,18	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	143	892	Escherichia_coli_EF_Tu	1185	1185	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1247	35.3	0	HET	.	.	.	T135C	.	135	135	T	159	159	T	31	T,C	18,11	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	143	892	Escherichia_coli_EF_Tu	1185	1185	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1247	35.3	0	HET	.	.	.	C216T	.	216	216	C	240	240	C	30	C,T	16,14	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	143	892	Escherichia_coli_EF_Tu	1185	134	95.52	Escherichia_coli_EF_Tu.l15.c17.ctg.3	170	0.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	294	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c30.ctg.1	1461	10.4	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1396	1398	AAA	5;6;6	A;A;A	5;6;6	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	364	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c30.ctg.1	1546	12.3	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1139	1141	GAA	14;15;15	G;A;A	14;15;15	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	19	72	H_NS	414	400	99.0	H_NS.l15.c30.ctg.2	409	7.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS;H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	362	PmrB_1	1092	1092	99.18	PmrB_1.l6.c4.ctg.1	1442	13.4	0	.	p	.	0	H2R	NONSYN	4	6	CAT	176	178	CGT	17;17;17	C;G;T	17;17;17	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	362	PmrB_1	1092	1092	99.18	PmrB_1.l6.c4.ctg.1	1442	13.4	0	.	p	.	0	V161G	NONSYN	481	483	GTG	653	655	GGG	9;8;8	G;G,T;G	8;2,2;8	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	362	PmrB_1	1092	1092	99.18	PmrB_1.l6.c4.ctg.1	1442	13.4	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1019	1021	GGC	22;22;22	G;G;C	22;22;22	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	444	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1927	12.3	0	.	p	.	0	R8S	NONSYN	22	24	AGA	168	170	AGC	8;8;8	A;G;C	8;8;7	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	444	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1927	12.3	0	.	p	.	0	I142L	NONSYN	424	426	ATA	570	572	CTA	12;12;12	C;T;A	12;12;12	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	444	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1927	12.3	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1089	1091	CAA	14;14;14	C;A;A	14;14;14	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	444	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1927	12.3	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1188	1190	GGT	17;17;17	G;G;T	17;17;17	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	444	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1927	12.3	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1758	1760	GTT	8;8;8	G;T;T	8;8;8	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	512	176	PmrE	1167	627	95.53	PmrE.l6.c30.ctg.1	628	6.9	0	.	p	.	0	M185T	NONSYN	553	555	ATG	13	15	ACC	2;2;2	A;C;C	2;2;2	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	512	176	PmrE	1167	627	95.53	PmrE.l6.c30.ctg.1	628	6.9	0	.	p	.	0	S225T	NONSYN	673	675	TCC	133	135	ACT	4;4;4	A;C;T	4;4;4	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	512	176	PmrE	1167	627	95.53	PmrE.l6.c30.ctg.1	628	6.9	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	523	525	ATC	4;4;4	A;T;C	4;4;4	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	512	176	PmrE	1167	325	99.69	PmrE.l6.c30.ctg.2	334	9.1	0	.	p	.	0	L13F	NONSYN	37	39	TTG	46	48	TTT	12;12;12	T;T;T,G	12;12;1,8	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	238	PmrF	969	969	99.38	PmrF.l15.c4.ctg.1	1237	10.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
TEM_124.3000986.AY327540.0_858.1398	TEM_124.3000986.AY327540.0_858.1398	1	0	512	28	TEM_1+	858	122	98.36	TEM_1+.l15.c4.ctg.1	122	2.7	0	.	p	.	0	T180M	NONSYN	538	540	ACG	38	40	ATG	3;3;4	A;T;G	3;3;4	.	TEM-124 is an extended-spectrum beta-lactamase found in Morganella morganii.;TEM-124
TEM_124.3000986.AY327540.0_858.1398	TEM_124.3000986.AY327540.0_858.1398	1	0	512	28	TEM_1+	858	122	98.36	TEM_1+.l15.c4.ctg.1	122	2.7	0	.	p	.	0	A182V	NONSYN	544	546	GCA	44	46	GTA	4;4;4	G;T;A	4;4;4	.	TEM-124 is an extended-spectrum beta-lactamase found in Morganella morganii.;TEM-124
TEM_124.3000986.AY327540.0_858.1398	TEM_124.3000986.AY327540.0_858.1398	1	0	512	28	TEM_1+	858	129	99.22	TEM_1+.l15.c4.ctg.2	129	2.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TEM-124 is an extended-spectrum beta-lactamase found in Morganella morganii.;TEM-124
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	722	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3312	11.7	0	.	p	.	0	T85I	NONSYN	253	255	ACC	449	451	ATC	11;10;9	A;T;C	11;10;9	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	722	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3312	11.7	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2162	2164	AAG	6;6;6	A;A;G	6;6;6	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	310	acrE	1158	1158	98.79	acrE.l15.c4.ctg.2	1328	12.1	0	.	p	.	0	A22V	NONSYN	64	66	GCC	174	176	GTC	2;3;4	G;T;C	2;3;4	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	310	acrE	1158	1158	98.79	acrE.l15.c4.ctg.2	1328	12.1	0	.	p	.	0	S269C	NONSYN	805	807	AGC	915	917	TGC	14;14;14	T;G;C	14;14;14	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	826	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3197	13.5	0	.	p	.	0	S46trunc	TRUNC	136	136	T	159	159	T	7	T	7	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	826	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3197	13.5	0	.	p	.	0	G148D	NONSYN	442	444	GGC	465	467	GAC	11;11;12	G;A;C	11;11;12	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	826	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3197	13.5	0	.	p	.	0	F240L	NONSYN	718	720	TTT	741	743	TTA	3;3;3	T;T;A	3;3;3	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	826	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3197	13.5	0	.	p	.	0	K599N	NONSYN	1795	1797	AAG	1818	1820	AAT	12;12;11	A;A;T	12;12;11	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	826	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3197	13.5	0	.	p	.	0	N637S	NONSYN	1909	1911	AAT	1932	1934	AGT	8;9;10	A;G;T	8;9;10	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	826	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3197	13.5	0	.	p	.	0	L770V	NONSYN	2308	2310	TTG	2331	2333	GTG	13;13;12	G;T;G	13;13;12	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	826	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3197	13.5	0	.	p	.	0	E955K	NONSYN	2863	2865	GAG	2886	2888	AAG	13;12;12	A;A;G	13;12;12	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	152	acrR_2	648	648	99.54	acrR_2.l15.c30.ctg.1	841	8.9	1	SNP	p	R45C	0	.	.	133	135	CGC	312	314	CGC	8;8;8	C;G;C	8;8;8	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	146	acrS	663	663	98.79	acrS.l15.c4.ctg.1	824	8.9	0	.	p	.	0	L34F	NONSYN	100	102	CTC	190	192	TTC	8;8;8	T;T;C	8;8;8	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	146	acrS	663	663	98.79	acrS.l15.c4.ctg.1	824	8.9	0	.	p	.	0	E122G	NONSYN	364	366	GAG	454	456	GGG	8;8;6	G;G;G	8;8;6	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	216	adiY	762	762	99.61	adiY.l15.c4.ctg.1	1040	10.5	0	.	p	.	0	V136L	NONSYN	406	408	GTT	630	632	CTT	12;12;12	C;T;T	12;12;12	.	adiY;adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	758	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	2991	13.7	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2024	2026	GCA	17;18;17	G;C;A	17;18;17	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	758	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	2991	13.7	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2285	2287	ACC	17;17;17	A;C;C	17;17;17	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	758	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	2991	13.7	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2594	2596	GCC	8;8;9	G;C;C	8;8;9	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	346	arnA_1	1983	1564	98.66	arnA_1.l6.c4.ctg.1	1564	10.2	0	.	p	.	0	I150V	NONSYN	448	450	ATT	29	31	GTT	10;10;11	G;T;T	10;10;11	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	346	arnA_1	1983	1564	98.66	arnA_1.l6.c4.ctg.1	1564	10.2	0	.	p	.	0	R200H	NONSYN	598	600	CGC	179	181	CAC	8;8;9	C;A;C	8;8;9	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	346	arnA_1	1983	1564	98.66	arnA_1.l6.c4.ctg.1	1564	10.2	0	.	p	.	0	T295M	NONSYN	883	885	ACG	464	466	ATG	14;14;14	A;T;G	14;13;14	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	346	arnA_1	1983	1564	98.66	arnA_1.l6.c4.ctg.1	1564	10.2	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	1460	1462	CGC	8;7;7	C;G;C	8;7;7	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	346	arnA_1	1983	381	97.11	arnA_1.l6.c4.ctg.2	381	5.1	0	.	p	.	0	G37A	NONSYN	109	111	GGT	107	109	GCT	2;2;2	G;C;T	2;2;2	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	346	arnA_1	1983	381	97.11	arnA_1.l6.c4.ctg.2	381	5.1	0	.	p	.	0	D77E	NONSYN	229	231	GAT	227	229	GAG	2;2;2	G;A;G	2;2;2	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	346	arnA_1	1983	381	97.11	arnA_1.l6.c4.ctg.2	381	5.1	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	263	265	TGC	2;2;2	T;G;C	2;2;2	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	202	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1032	10.1	0	.	p	.	0	S221T	NONSYN	661	663	AGC	722	724	ACC	4;4;4	A;C;C	4;4;4	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	202	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1032	10.1	0	.	p	.	0	P225S	NONSYN	673	675	CCG	734	736	TCG	5;5;6	T;C;G	5;5;6	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	19	166	baeR	723	635	97.8	baeR.l15.c4.ctg.1	828	10.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	284	baeS	1404	1404	98.86	baeS.l6.c4.ctg.1	1568	9.3	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1280	1282	AAA	5;5;5	A;A;A	5;5;5	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	284	baeS	1404	1404	98.86	baeS.l6.c4.ctg.1	1568	9.3	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1292	1294	GAG	6;6;6	G;A;G	6;5;6	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	284	baeS	1404	1404	98.86	baeS.l6.c4.ctg.1	1568	9.3	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1298	1300	CAC	7;6;6	C;A;C	7;6;6	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	284	baeS	1404	1404	98.86	baeS.l6.c4.ctg.1	1568	9.3	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1352	1354	GAG	10;10;11	G;A;G	10;10;11	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	539	468	cpxA	1374	1374	98.76	cpxA.l6.c4.ctg.1	1579	15.4	0	.	p	.	0	A231T	NONSYN	691	693	GCG	861	863	ACG	15;15;14	A;C;G	14;15;14	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	258	cpxR	699	699	99.43	cpxR.l6.c4.ctg.1	1031	13.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.;cpxR
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	178	cysB	975	975	99.28	cysB.l15.c4.ctg.2	1140	8.0	0	.	p	.	0	T132I	NONSYN	394	396	ACA	458	460	ATA	9;9;9	A;T,C;A	9;8,1;9	.	Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.;aminocoumarin resistant cysB
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	298	emrA	1173	1173	98.38	emrA.l15.c30.ctg.1	1384	11.3	0	.	p	.	0	I219V	NONSYN	655	657	ATC	814	816	GTC	15;16;16	G;T;C	14;16;16	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	27	442	emrB	1539	1539	99.81	emrB.l6.c4.ctg.1	1902	12.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.;emrB
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	286	emrD	1191	1191	98.57	emrD.l6.c4.ctg.1	1591	9.7	0	.	p	.	0	G209S	NONSYN	625	627	GGC	839	841	AGC	8;8;8	A;G;C	8;8;8	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	16	emrE_1	333	76	96.05	emrE_1.l15.c4.ctg.1	76	4.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.;emrE
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	513	206	emrK	1056	892	98.21	emrK.l15.c30.ctg.1	1000	8.8	0	.	p	.	0	K176R	NONSYN	526	528	AAG	634	636	AGG	8;8;8	A;G;G	8;8;8	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	513	206	emrK	1056	156	98.72	emrK.l15.c30.ctg.2	178	9.4	0	.	p	.	0	N306D	NONSYN	916	918	AAC	16	18	GAC	5;5;5	G;A;C	5;5;5	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	164	emrR	531	531	100.0	emrR.l6.c4.ctg.1	842	10.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	300	emrY	1539	1539	99.81	emrY.l15.c17.ctg.1	1675	9.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	88	evgA	615	615	99.19	evgA.l15.c4.ctg.1	805	5.8	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	205	207	CTG	7;7;7	C;T;G	7;7;7	.	evgA;EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	580	evgS	3594	2443	97.91	evgS.l6.c4.ctg.1	2614	9.1	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	146	148	AAA	3;3;3	A;A;A	3;3;3	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	580	evgS	3594	2443	97.91	evgS.l6.c4.ctg.1	2614	9.1	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	881	883	CAT	13;13;13	C;A;T	13;13;13	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	580	evgS	3594	2443	97.91	evgS.l6.c4.ctg.1	2614	9.1	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	935	937	CAT	5;5;5	C;A;T	5;5;5	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	580	evgS	3594	2443	97.91	evgS.l6.c4.ctg.1	2614	9.1	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	953	955	AGA	4;4;3	A;G;A	4;4;3	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	580	evgS	3594	2443	97.91	evgS.l6.c4.ctg.1	2614	9.1	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	968	970	AAT	4;4;4	A;A;T	4;4;4	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	580	evgS	3594	2443	97.91	evgS.l6.c4.ctg.1	2614	9.1	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	1115	1117	TCC	4;4;4	T;C;C	3;3;4	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	580	evgS	3594	2443	97.91	evgS.l6.c4.ctg.1	2614	9.1	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	1280	1282	ATT	4;4;4	A;T;T	4;4;4	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	580	evgS	3594	2443	97.91	evgS.l6.c4.ctg.1	2614	9.1	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	1301	1303	GAT	9;10;10	G;A;T	9;10;9	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	580	evgS	3594	2443	97.91	evgS.l6.c4.ctg.1	2614	9.1	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	1415	1417	GTT	12;12;11	G;T;T	12;12;11	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	580	evgS	3594	2443	97.91	evgS.l6.c4.ctg.1	2614	9.1	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	1700	1702	CAC	3;2;3	C;A;C	3;2;3	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	580	evgS	3594	759	97.23	evgS.l6.c4.ctg.2	759	6.4	0	.	p	.	0	A93T	NONSYN	277	279	GCG	150	152	ACG	5;5;5	A;C;G	5;5;5	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	580	evgS	3594	759	97.23	evgS.l6.c4.ctg.2	759	6.4	0	.	p	.	0	A114E	NONSYN	340	342	GCA	213	215	GAA	6;6;7	G;A;A	6;6;7	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	580	evgS	3594	759	97.23	evgS.l6.c4.ctg.2	759	6.4	0	.	p	.	0	T127A	NONSYN	379	381	ACT	252	254	GCT	8;8;8	G;C;T	8;8;8	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	580	evgS	3594	759	97.23	evgS.l6.c4.ctg.2	759	6.4	0	.	p	.	0	N133D	NONSYN	397	399	AAT	270	272	GAT	6;6;6	G;A;T	6;6;6	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	580	evgS	3594	759	97.23	evgS.l6.c4.ctg.2	759	6.4	0	.	p	.	0	P162S	NONSYN	484	486	CCA	357	359	TCA	5;5;4	T;C;A	5;5;4	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	580	evgS	3594	759	97.23	evgS.l6.c4.ctg.2	759	6.4	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	486	488	CAG	5;5;4	C;A;G	5;5;4	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	580	evgS	3594	759	97.23	evgS.l6.c4.ctg.2	759	6.4	0	.	p	.	0	I251V	NONSYN	751	753	ATT	624	626	GTT	8;8;8	G;T;T	8;8;8	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	580	evgS	3594	112	100.0	evgS.l6.c4.ctg.3	198	5.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	580	evgS	3594	131	96.95	evgS.l6.c4.ctg.4	131	5.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	226	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1084	11.1	1	SNP	p	P64L	0	.	.	190	192	CCA	303	305	CCA	18;20;21	C;C;A	18;20;21	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	226	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1084	11.1	1	SNP	p	P64R	0	.	.	190	192	CCA	303	305	CCA	18;20;21	C;C;A	18;20;21	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	226	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1084	11.1	1	SNP	p	P64H	0	.	.	190	192	CCA	303	305	CCA	18;20;21	C;C;A	18;20;21	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	226	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1084	11.1	1	SNP	p	P64A	0	.	.	190	192	CCA	303	305	CCA	18;20;21	C;C;A	18;20;21	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	226	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1084	11.1	1	SNP	p	P64S	0	.	.	190	192	CCA	303	305	CCA	18;20;21	C;C;A	18;20;21	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	16	76	gadE	528	272	100.0	gadE.l15.c30.ctg.1	507	7.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.;gadE
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	678	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2885	12.5	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2097	2099	GAA	10;8;8	G;A;A	10;8;8	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	678	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2885	12.5	1	SNP	p	S83L	0	.	.	247	249	TCG	312	314	TCG	5;5;6	T;C;G	5;5;6	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	678	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2885	12.5	1	SNP	p	S83W	0	.	.	247	249	TCG	312	314	TCG	5;5;6	T;C;G	5;5;6	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	678	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2885	12.5	1	SNP	p	S83I	0	.	.	247	249	TCG	312	314	TCG	5;5;6	T;C;G	5;5;6	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	678	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2885	12.5	1	SNP	p	D87Y	0	.	.	259	261	GAC	324	326	GAC	8;8;8	G;A;C	8;8;8	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	678	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2885	12.5	1	SNP	p	D87N	0	.	.	259	261	GAC	324	326	GAC	8;8;8	G;A;C	8;8;8	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	678	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2885	12.5	1	SNP	p	D87V	0	.	.	259	261	GAC	324	326	GAC	8;8;8	G;A;C	8;8;8	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	678	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2885	12.5	1	SNP	p	D87H	0	.	.	259	261	GAC	324	326	GAC	8;8;8	G;A;C	8;8;8	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	678	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2885	12.5	1	SNP	p	D87G	0	.	.	259	261	GAC	324	326	GAC	8;8;8	G;A;C	8;8;8	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	650	gyrB_1	2415	2415	99.13	gyrB_1.l15.c30.ctg.1	2618	13.1	1	SNP	p	R136I	0	.	.	406	408	CGC	584	586	CGC	17;17;19	C;G;C	17;17;19	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	650	gyrB_1	2415	2415	99.13	gyrB_1.l15.c30.ctg.1	2618	13.1	1	SNP	p	R136S	0	.	.	406	408	CGC	584	586	CGC	17;17;19	C;G;C	17;17;19	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	650	gyrB_1	2415	2415	99.13	gyrB_1.l15.c30.ctg.1	2618	13.1	1	SNP	p	R136C	0	.	.	406	408	CGC	584	586	CGC	17;17;19	C;G;C	17;17;19	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	650	gyrB_1	2415	2415	99.13	gyrB_1.l15.c30.ctg.1	2618	13.1	1	SNP	p	R136E	0	.	.	406	408	CGC	584	586	CGC	17;17;19	C;G;C	17;17;19	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	650	gyrB_1	2415	2415	99.13	gyrB_1.l15.c30.ctg.1	2618	13.1	1	SNP	p	R136L	0	.	.	406	408	CGC	584	586	CGC	17;17;19	C;G;C	17;17;19	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	650	gyrB_1	2415	2415	99.13	gyrB_1.l15.c30.ctg.1	2618	13.1	1	SNP	p	R136G	0	.	.	406	408	CGC	584	586	CGC	17;17;19	C;G;C	17;17;19	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	650	gyrB_1	2415	2415	99.13	gyrB_1.l15.c30.ctg.1	2618	13.1	1	SNP	p	R136H	0	.	.	406	408	CGC	584	586	CGC	17;17;19	C;G;C	17;17;19	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	150	kdpE	678	678	98.08	kdpE.l15.c30.ctg.1	994	8.1	0	.	p	.	0	A72P	NONSYN	214	216	GCG	417	419	CCG	9;9;9	C;C;G	9;9;9	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	150	kdpE	678	678	98.08	kdpE.l15.c30.ctg.1	994	8.1	0	.	p	.	0	T123A	NONSYN	367	369	ACC	570	572	GCC	13;13;13	G;C;C	13;13;13	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	290	leuO	945	945	99.26	leuO.l15.c4.ctg.1	1163	13.3	0	.	p	.	0	P9S	NONSYN	25	27	CCA	64	66	TCA	19;19;18	T;C;A	19;19;18	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	80	marA	384	384	99.74	marA.l15.c30.ctg.1	517	7.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.;marA
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	38	marR	435	394	97.97	marR.l6.c30.ctg.1	407	3.9	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	320	322	AGC	6;6;6	A;G;C	6;6;6	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	38	marR	435	394	97.97	marR.l6.c30.ctg.1	407	3.9	1	SNP	p	V45E	0	.	.	133	135	GTG	146	148	GTG	10;10;10	G;T;G	10;10;10	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	38	marR	435	394	97.97	marR.l6.c30.ctg.1	407	3.9	1	SNP	p	I49S	0	.	.	145	147	ATC	158	160	ATC	8;8;8	A;T;C	8;8;8	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	38	marR	435	394	97.97	marR.l6.c30.ctg.1	407	3.9	1	SNP	p	A70T	0	.	.	208	210	GCA	221	223	GCA	1;1;1	G;C;A	1;1;1	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	38	marR	435	394	97.97	marR.l6.c30.ctg.1	407	3.9	1	SNP	p	R73S	0	.	.	217	219	CGT	230	232	CGT	1;1;1	C;G;T	1;1;1	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	38	marR	435	394	97.97	marR.l6.c30.ctg.1	407	3.9	1	SNP	p	R73C	0	.	.	217	219	CGT	230	232	CGT	1;1;1	C;G;T	1;1;1	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	38	marR	435	394	97.97	marR.l6.c30.ctg.1	407	3.9	1	SNP	p	R77C	0	.	.	229	231	CGC	242	244	CGC	2;2;2	C;G;C	2;2;2	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	38	marR	435	394	97.97	marR.l6.c30.ctg.1	407	3.9	1	SNP	p	R77L	0	.	.	229	231	CGC	242	244	CGC	2;2;2	C;G;C	2;2;2	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	38	marR	435	394	97.97	marR.l6.c30.ctg.1	407	3.9	1	SNP	p	L78M	0	.	.	232	234	CTG	245	247	CTG	2;2;2	C;T;G	2;2;2	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	38	marR	435	394	97.97	marR.l6.c30.ctg.1	407	3.9	1	SNP	p	R94S	0	.	.	280	282	CGC	293	295	CGC	5;5;5	C;G;C	5;5;5	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	38	marR	435	394	97.97	marR.l6.c30.ctg.1	407	3.9	1	SNP	p	R94H	0	.	.	280	282	CGC	293	295	CGC	5;5;5	C;G;C	5;5;5	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	38	marR	435	394	97.97	marR.l6.c30.ctg.1	407	3.9	1	SNP	p	V96E	0	.	.	286	288	GTA	299	301	GTA	5;5;6	G;T;A	5;5;6	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	150	mdfA	1233	102	97.06	mdfA.l6.c30.ctg.1	221	4.9	0	.	p	.	0	L379Q	NONSYN	1135	1137	CTG	4	6	CAG	6;6;6	C;A;G	2;2;2	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	150	mdfA	1233	102	97.06	mdfA.l6.c30.ctg.1	221	4.9	0	.	p	.	0	L391W	NONSYN	1171	1173	TTG	40	42	TGG	8;8;8	T;G;G	8;8;8	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	150	mdfA	1233	102	97.06	mdfA.l6.c30.ctg.1	221	4.9	0	.	p	.	0	L399trunc	TRUNC	1195	1195	T	64	64	T	8	T	8	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	150	mdfA	1233	919	97.17	mdfA.l6.c30.ctg.2	914	6.1	0	.	p	.	0	E52D	NONSYN	154	156	GAG	8	10	GAT	1;1;1	G;A;T	1;1;1	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	150	mdfA	1233	919	97.17	mdfA.l6.c30.ctg.2	914	6.1	0	.	p	.	0	N59T	NONSYN	175	177	AAC	29	31	ACC	5;5;5	A;C;C	5;5;5	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	150	mdfA	1233	919	97.17	mdfA.l6.c30.ctg.2	914	6.1	0	.	p	.	0	I68L	NONSYN	202	204	ATA	56	58	TTA	5;5;5	T;T;A	5;5;5	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	150	mdfA	1233	919	97.17	mdfA.l6.c30.ctg.2	914	6.1	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	197	199	CAG	7;7;7	C;A;G	7;7;7	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	150	mdfA	1233	919	97.17	mdfA.l6.c30.ctg.2	914	6.1	0	.	p	.	0	D128A	NONSYN	382	384	GAC	236	238	GCC	3;3;3	G;C;C	3;3;3	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	150	mdfA	1233	919	97.17	mdfA.l6.c30.ctg.2	914	6.1	0	.	p	.	0	S163A	NONSYN	487	489	TCG	341	343	GCG	3;3;4	G;C;G	2;3;4	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	150	mdfA	1233	919	97.17	mdfA.l6.c30.ctg.2	914	6.1	0	.	p	.	0	L231V	NONSYN	691	693	CTT	545	547	GTT	6;7;7	G;T;T	6;7;7	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	150	mdfA	1233	919	97.17	mdfA.l6.c30.ctg.2	914	6.1	0	.	p	.	0	R285fs	FSHIFT	853	853	C	707	707	C	4	C	4	.	Multidrug translocase MdfA;mdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	512	224	mdtA	1248	677	98.38	mdtA.l6.c30.ctg.1	793	10.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	512	224	mdtA	1248	215	96.74	mdtA.l6.c30.ctg.2	215	4.9	0	.	p	.	0	I99M	NONSYN	295	297	ATA	2	4	ATG	2;2;2	A;T;G	1;2;2	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	512	224	mdtA	1248	215	96.74	mdtA.l6.c30.ctg.2	215	4.9	0	.	p	.	0	A130T	NONSYN	388	390	GCC	95	97	ACC	6;6;6	A;C;C	6;6;6	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	786	mdtB	3123	3123	98.94	mdtB.l6.c4.ctg.1	3373	12.5	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1926	1928	ACC	22;22;22	A;C;C	22;22;22	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	786	mdtB	3123	3123	98.94	mdtB.l6.c4.ctg.1	3373	12.5	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2319	2321	CAA	8;8;8	C;A;A	8;8;8	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	786	mdtB	3123	3123	98.94	mdtB.l6.c4.ctg.1	3373	12.5	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2487	2489	ATT	9;9;9	A;T;T	9;9;9	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	786	mdtB	3123	3123	98.94	mdtB.l6.c4.ctg.1	3373	12.5	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2571	2573	GTT	13;13;13	G;T;T	13;13;13	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	786	mdtB	3123	3123	98.94	mdtB.l6.c4.ctg.1	3373	12.5	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2679	2681	GAG	9;9;9	G;A;G	8;9;9	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	786	mdtB	3123	3123	98.94	mdtB.l6.c4.ctg.1	3373	12.5	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2907	2909	ATG	11;12;12	A;T;G	11;12;12	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	786	mdtB	3123	3123	98.94	mdtB.l6.c4.ctg.1	3373	12.5	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3042	3044	GAT	8;7;7	G;A;T	8;7;7	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	515	662	mdtC	3078	2893	98.72	mdtC.l15.c4.ctg.1	2893	11.6	0	.	p	.	0	I46M	NONSYN	136	138	ATC	83	85	ATG	8;9;9	A;T;G	8;9;9	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	515	662	mdtC	3078	2893	98.72	mdtC.l15.c4.ctg.1	2893	11.6	0	.	p	.	0	V208I	NONSYN	622	624	GTC	569	571	ATC	12;12;11	A;T;C	12;12;11	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	515	662	mdtC	3078	2893	98.72	mdtC.l15.c4.ctg.1	2893	11.6	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	2885	2887	CAC	2;1;1	C;A;C	2;1;1	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	515	662	mdtC	3078	145	97.24	mdtC.l15.c4.ctg.2	164	4.6	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	5	7	CAC	3;3;3	C;A;C	3;2;3	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	298	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1611	9.7	0	.	p	.	0	D3E	NONSYN	7	9	GAT	20	22	GAA	3;3;3	G;A;A	3;3;3	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	298	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1611	9.7	0	.	p	.	0	T226A	NONSYN	676	678	ACG	689	691	GCG	16;15;13	G;C,G;G	15;13,1;13	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	298	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1611	9.7	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1031	1033	ATC	11;11;12	A;T;C	9;11;11	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	298	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1611	9.7	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1334	1336	TTT	9;9;9	T;T;T	9;9;9	.	Efflux pump mdtD;mdtD
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	266	mdtG	1227	1047	99.43	mdtG.l6.c4.ctg.1	1323	8.8	0	.	p	.	0	V200I	NONSYN	598	600	GTC	577	579	ATC	8;8;9	A;T;C	7;8;9	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	266	mdtG	1227	172	99.42	mdtG.l6.c4.ctg.2	321	6.0	0	.	p	.	0	E5G	NONSYN	13	15	GAA	162	164	GGA	1;1;1	G;G;A	1;1;1	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	531	266	mdtH	1209	1207	98.09	mdtH.l15.c4.ctg.1	1213	11.2	0	.	p	.	0	G134C	NONSYN	400	402	GGT	398	400	TGT	19;18;18	T;G;T	19;18;18	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	531	266	mdtH	1209	1207	98.09	mdtH.l15.c4.ctg.1	1213	11.2	0	.	p	.	0	S324L	NONSYN	970	972	TCG	968	970	TTG	11;11;11	T;T;G	11;11;10	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	531	266	mdtH	1209	1207	98.09	mdtH.l15.c4.ctg.1	1213	11.2	0	.	p	.	0	L359Q	NONSYN	1075	1077	CTG	1073	1075	CAG	4;4;4	C;A;G	4;4;4	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	531	266	mdtH	1209	1207	98.09	mdtH.l15.c4.ctg.1	1213	11.2	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1178	1180	ACG	6;6;6	A;C;G	6;6;6	.	mdtH;Multidrug resistance protein MdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	338	mdtL	1176	1176	98.47	mdtL.l15.c4.ctg.1	1541	11.8	0	.	p	.	0	A185S	NONSYN	553	555	GCC	744	746	TCC	14;14;14	T;C;C	14;14;14	.	mdtL;Multidrug resistance protein MdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	196	mdtN	1032	1032	98.16	mdtN.l6.c4.ctg.1	1263	8.0	0	.	p	.	0	V119I	NONSYN	355	357	GTT	528	530	ATT	6;6;6	A;T;T	6;6;6	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.;mdtN
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	548	mdtO	2052	2052	98.15	mdtO.l6.c4.ctg.1	2111	13.4	0	.	p	.	0	V11M	NONSYN	31	33	GTG	66	68	ATG	5;5;5	A;T;G	5;5;5	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	548	mdtO	2052	2052	98.15	mdtO.l6.c4.ctg.1	2111	13.4	0	.	p	.	0	T33I	NONSYN	97	99	ACC	132	134	ATC	14;14;15	A;T;C	12;13;14	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	548	mdtO	2052	2052	98.15	mdtO.l6.c4.ctg.1	2111	13.4	0	.	p	.	0	C116R	NONSYN	346	348	TGC	381	383	CGC	13;13;14	C;G;C	13;13;14	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	548	mdtO	2052	2052	98.15	mdtO.l6.c4.ctg.1	2111	13.4	0	.	p	.	0	N238S	NONSYN	712	714	AAC	747	749	AGC	22;22;22	A;G;C	21;21;21	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	548	mdtO	2052	2052	98.15	mdtO.l6.c4.ctg.1	2111	13.4	0	.	p	.	0	M305V	NONSYN	913	915	ATG	948	950	GTG	19;18;16	G;T;G	19;17;16	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	548	mdtO	2052	2052	98.15	mdtO.l6.c4.ctg.1	2111	13.4	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1011	1013	AAC	7;7;7	A;A;C	7;7;6	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	548	mdtO	2052	2052	98.15	mdtO.l6.c4.ctg.1	2111	13.4	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1056	1058	GTC	11;11;11	G;T;C	11;10;11	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	548	mdtO	2052	2052	98.15	mdtO.l6.c4.ctg.1	2111	13.4	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1086	1088	ATA	13;13;12	A;T;A	13;13;12	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	548	mdtO	2052	2052	98.15	mdtO.l6.c4.ctg.1	2111	13.4	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1194	1196	TCT	4;5;5	T;C;T	4;5;5	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	548	mdtO	2052	2052	98.15	mdtO.l6.c4.ctg.1	2111	13.4	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1581	1583	GCG	15;15;15	G;C;G	15;15;15	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	548	mdtO	2052	2052	98.15	mdtO.l6.c4.ctg.1	2111	13.4	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1794	1796	ATC	10;10;10	A;T;C	10;9;9	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	352	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1538	12.1	0	.	p	.	0	S129A	NONSYN	385	387	TCA	417	419	GCG	12;12;12	G;C;G	12;12;12	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	352	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1538	12.1	0	.	p	.	0	A187T	NONSYN	559	561	GCC	591	593	ACC	8;8;8	A;C;C	8;8;8	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	352	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1538	12.1	0	.	p	.	0	H211R	NONSYN	631	633	CAC	663	665	CGC	10;8;9	C;G;C	10;8;9	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	352	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1538	12.1	0	.	p	.	0	V250A	NONSYN	748	750	GTT	780	782	GCT	17;17;17	G;C;T	16;16;17	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	352	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1538	12.1	0	.	p	.	0	R278K	NONSYN	832	834	AGA	864	866	AAA	7;7;7	A;A;A	7;7;7	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	352	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1538	12.1	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	882	884	CGA	9;9;8	C;G;A	9;9;8	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	352	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1538	12.1	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1047	1049	GCC	9;9;9	G;C;C	9;9;9	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	352	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1538	12.1	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1059	1061	GAT	9;10;10	G;A;T	9;10;10	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	352	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1538	12.1	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1476	1478	GCT	4;4;4	G;C;T	4;4;4	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	706	mfd	3447	3447	99.16	mfd.l6.c30.ctg.1	3740	10.1	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1449	1451	AAG	3;3;3	A;A;G	3;3;3	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	706	mfd	3447	3447	99.16	mfd.l6.c30.ctg.1	3740	10.1	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2526	2528	CTG	12;12;12	C;T;G	12;12;12	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	36	mgrB	144	144	100.0	mgrB.l15.c30.ctg.2	163	6.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae;mgrB
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	464	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	1922	12.8	0	.	p	.	0	S278N	NONSYN	832	834	AGC	955	957	AAC	10;10;10	A;A;C	10;10;10	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	464	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	1922	12.8	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1501	1503	ATA	15;15;16	A;T;A	15;15;16	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	318	murA_12	1260	1260	98.49	murA_12.l6.c4.ctg.1	1477	11.4	0	.	p	.	0	A343V	NONSYN	1027	1029	GCG	1190	1192	GTG	12;12;12	G;T;G	12;12;12	.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	318	murA_12	1260	1260	98.49	murA_12.l6.c4.ctg.1	1477	11.4	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1268	1270	GAT	15;15;14	G;A;T	15;15;14	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	318	murA_12	1260	1260	98.49	murA_12.l6.c4.ctg.1	1477	11.4	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1271	1273	CTG	13;13;11	C;T;G	13;13;11	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	156	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1088	7.6	0	.	p	.	0	R27C	NONSYN	79	81	CGT	262	264	TGT	4;4;7	T;G;T	4;4;7	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	156	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1088	7.6	0	.	p	.	0	I117T	NONSYN	349	351	ATC	532	534	ACC	9;9;9	A;C;C	8;9;9	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	156	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1088	7.6	0	.	p	.	0	G187D	NONSYN	559	561	GGC	742	744	GAC	9;9;9	G;A;C	9;9;9	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	156	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1088	7.6	1	SNP	p	R15C	0	.	.	43	45	CGC	226	228	CGC	17;15;15	C;G;C	17;15;15	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	156	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1088	7.6	1	SNP	p	S33R	0	.	.	97	99	AGC	280	282	AGC	8;8;8	A;G;C	8;8;8	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	156	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1088	7.6	1	SNP	p	G131D	0	.	.	391	393	GGC	574	576	GGC	11;10;10	G;G;C	11;10;9	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	156	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1088	7.6	1	SNP	p	R203L	0	.	.	607	609	CGT	790	792	CGT	5;5;5	C;G;T	5;5;5	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	156	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1088	7.6	1	SNP	p	R203C	0	.	.	607	609	CGT	790	792	CGT	5;5;5	C;G;T	5;5;5	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	338	ompF	1089	1089	100.0	ompF.l6.c30.ctg.1	1359	13.3	1	SNP	p	G141E	0	.	.	421	423	GGT	535	537	GGT	8;8;8	G;G;T	8;8;8	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	338	ompF	1089	1089	100.0	ompF.l6.c30.ctg.1	1359	13.3	1	SNP	p	G141D	0	.	.	421	423	GGT	535	537	GGT	8;8;8	G;G;T	8;8;8	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	338	ompF	1089	1089	100.0	ompF.l6.c30.ctg.1	1359	13.3	1	SNP	p	R154D	0	.	.	460	462	CGT	574	576	CGT	13;13;13	C;G;T	13;13;13	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	338	ompF	1089	1089	100.0	ompF.l6.c30.ctg.1	1359	13.3	1	SNP	p	R154A	0	.	.	460	462	CGT	574	576	CGT	13;13;13	C;G;T	13;13;13	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	710	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2653	14.4	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1859	1861	TCG	19;16;16	T;C;G	17;16;16	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	710	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2653	14.4	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2474	2476	AAC	7;7;8	A;A;C	7;7;8	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	710	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2653	14.4	1	SNP	p	A85T	0	.	.	253	255	GCG	488	490	GCG	15;14;14	G;C;G	14;14;14	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	710	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2653	14.4	1	SNP	p	D111H	0	.	.	331	333	GAT	566	568	GAT	9;9;10	G;A;T	9;9;10	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	710	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2653	14.4	1	SNP	p	S129P	0	.	.	385	387	TCC	620	622	TCC	18;18;18	T;C;C	18;18;18	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	27	440	parE_1	1893	1893	97.52	parE_1.l15.c30.ctg.1	2098	11.0	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1449	1451	GAT	18;16;16	G;A;T	17;15;16	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	378	patA	1380	1380	99.86	patA.l15.c30.ctg.1	1747	11.5	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1250	1252	GAT	12;13;13	G;A;T	12;13;13	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1352	rpoB	4029	4029	99.03	rpoB.l6.c17.ctg.1	4409	16.5	1	SNP	p	V146F	0	.	.	436	438	GTT	632	634	GTT	18;18;17	G;T;T	18;18;17	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1352	rpoB	4029	4029	99.03	rpoB.l6.c17.ctg.1	4409	16.5	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1733	1735	CAG	22;23;24	C;A;G	22;22;24	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1352	rpoB	4029	4029	99.03	rpoB.l6.c17.ctg.1	4409	16.5	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1733	1735	CAG	22;23;24	C;A;G	22;22;24	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1352	rpoB	4029	4029	99.03	rpoB.l6.c17.ctg.1	4409	16.5	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1772	1774	CAC	20;21;23	C;A;C	20;21;23	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1352	rpoB	4029	4029	99.03	rpoB.l6.c17.ctg.1	4409	16.5	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1781	1783	CGT	18;18;18	C;G;T	18;18;18	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1352	rpoB	4029	4029	99.03	rpoB.l6.c17.ctg.1	4409	16.5	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1781	1783	CGT	18;18;18	C;G;T	18;18;18	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1352	rpoB	4029	4029	99.03	rpoB.l6.c17.ctg.1	4409	16.5	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1787	1789	TCC	17;17;16	T;C;C	17;17;16	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1352	rpoB	4029	4029	99.03	rpoB.l6.c17.ctg.1	4409	16.5	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1793	1795	CTC	14;14;14	C;T;C	14;14;14	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1352	rpoB	4029	4029	99.03	rpoB.l6.c17.ctg.1	4409	16.5	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1883	1885	ACC	21;21;21	A;C;C	21;21;21	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1352	rpoB	4029	4029	99.03	rpoB.l6.c17.ctg.1	4409	16.5	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1886	1888	CCT	19;19;18	C;C;T	19;19;18	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1352	rpoB	4029	4029	99.03	rpoB.l6.c17.ctg.1	4409	16.5	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2255	2257	CGT	18;18;18	C;G;T	18;18;18	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3190	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1875	89.5	0	.	n	.	0	A226G	SNP	226	226	A	362	362	G	112	G	112	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3190	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1875	89.5	1	SNP	n	A794T	0	.	.	794	794	A	930	930	A	81	A	80	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3190	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1875	89.5	1	SNP	n	A794G	0	.	.	794	794	A	930	930	A	81	A	80	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3190	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1875	89.5	1	SNP	n	G926A	0	.	.	926	926	G	1062	1062	G	111	G	110	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3190	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1875	89.5	1	SNP	n	G926C	0	.	.	926	926	G	1062	1062	G	111	G	110	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3190	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1875	89.5	1	SNP	n	G926T	0	.	.	926	926	G	1062	1062	G	111	G	110	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3190	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1875	89.5	1	SNP	n	A1519G	0	.	.	1519	1519	A	1655	1655	A	73	A	73	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3190	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1875	89.5	1	SNP	n	A1519T	0	.	.	1519	1519	A	1655	1655	A	73	A	73	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3190	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1875	89.5	1	SNP	n	A1519C	0	.	.	1519	1519	A	1655	1655	A	73	A	73	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3190	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1875	89.5	0	HET	.	.	.	T90C	.	90	90	T	226	226	T	81	T,C	63,18	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3190	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1875	89.5	0	HET	.	.	.	A250T	.	250	250	A	386	386	A	103	A,T	72,31	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3190	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1875	89.5	0	HET	.	.	.	G474A	.	474	474	G	610	610	G	105	G,A	80,25	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3190	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1875	89.5	0	HET	.	.	.	A253T	.	253	253	A	389	389	A	99	A,T	67,31	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3190	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1875	89.5	0	HET	.	.	.	C194T	.	194	194	C	330	330	C	96	C,T	74,21	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3190	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1875	89.5	0	HET	.	.	.	G1002A,T	.	1002	1002	G	1138	1138	G	95	G,A,T	70,24,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3190	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1875	89.5	0	HET	.	.	.	G1006C	.	1006	1006	G	1142	1142	G	95	G,C	67,26	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3190	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1875	89.5	0	HET	.	.	.	A79G	.	79	79	A	215	215	A	73	A,G	57,15	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3190	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1875	89.5	0	HET	.	.	.	C719T	.	719	719	C	855	855	C	72	C,T	36,36	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3190	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1875	89.5	0	HET	.	.	.	T273A	.	273	273	T	409	409	T	95	T,A	72,19	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3190	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1875	89.5	0	HET	.	.	.	T1010C	.	1010	1010	T	1146	1146	T	100	T,C	72,26	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3190	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1875	89.5	0	HET	.	.	.	C1038T	.	1038	1038	C	1174	1174	C	97	C,T	71,26	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	3190	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1875	89.5	0	HET	.	.	.	C183T	.	183	183	C	319	319	C	95	C,T	61,32	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	146	soxR	465	465	100.0	soxR.l15.c30.ctg.1	624	12.1	1	SNP	p	R20H	0	.	.	58	60	CGC	132	134	CGC	16;16;16	C;G;C	16;16;16	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	146	soxR	465	465	100.0	soxR.l15.c30.ctg.1	624	12.1	1	SNP	p	G121D	0	.	.	361	363	GGT	435	437	GGT	17;17;17	G;G;T	17;16;17	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	104	soxS_1	324	324	99.69	soxS_1.l15.c30.ctg.1	472	9.6	1	SNP	p	A12S	0	.	.	34	36	GCA	139	141	GCA	12;11;11	G;C;A	12;11;11	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	382	tolC	1488	1488	98.72	tolC.l6.c30.ctg.1	1650	11.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
